We observed a reduction in tumour growth after BPTF-silencing that was dramatically augmented with gemcitabine treatment (Figure 4B), indicating that BPTF-silencing indeed sensitizes tumour cells to gemcitabine. Here, BPTF is linked to neoplasm.